MKI The Medipattern Corp.

Attention: Business/Financial Editors

The Medipattern Corporation ("Medipattern") (TSX VENTURE:MKI), a pioneer in the
development of medical imaging software solutions that help medical
practitioners to better understand lesions and critical anatomy, announced today
that the Company was featured for a second time on the Money on the Mark radio
program hosted by Dale Jackson in New York. The program can be downloaded from
www.medipattern.com. The interview focuses on use of Visualize:Vascular(TM) in a
cardiology practice and their diagnostic services provider, Navix Diagnostix.
Navix is one of Medipattern's channel partners.


"It (Visualize:Vascular(TM)) can mean the difference between continued medical
therapy and the patient going to a surgical revascularization or stenting,"
commented Dr. Robert Jumper, FACC, RVPI, Interventional Cardiologist with
Cardiology of Fairfield County (CAFC), located in Connecticut. "It gives us a
more complete picture and a better sense of the disease process in order to
better treat the patient and get them to the appropriate course of therapy,
whether it be continued preventive care and avoiding pre-mature surgery; or
surgery and forgoing further preventive care."


Robert Kane, Senior Vice President of Clinical Services at Navix was interviewed
in another segment where he commented, "It's sort of like radio and television.
(Visualize:Vascular(TM)) is like having a 3D TV as compared to what we did
before was radio. 2D would be viewed as being flat. The vessel is a tube so it
has 3 dimensions. We are able to see things with Medipattern that we have never
been able to see before." Kane continued to comment regarding possible future
applications for the technology, "We believe that there are many more
applications for this: lower aorta, femoral artery and veins. Being able to see
inside that vessel that is not functioning like it usually does is really a
tremendous help. There are massive applications for this."


"Medipattern appreciates our early data collection work hosted by CAFC in
support of developing our vascular product," commented Medipattern CEO Jeff
Collins. "Medipattern is pleased to continue to foster our relationship with
Navix. The two companies have recently included reciprocating web pages.
Medipattern is seen on the Navix home page, www.navixdiagnostix.com and Navix's
sub page, http://www.navixdiagnostix.com/3dreconimg.cfm. And Navix is seen on
Medipattern's Solutions page
http://www.medipattern.com/solutions_vascular_bundled.aspx. Navix is in the
process of proceeding with its planned product roll out for
Visualize:Vascular(TM) including it within Navix's service offerings."


Upcoming Events



45th Annual Mid-Winter Leadership                                           
 Conference MHA                               Jan 27, 2012    Framingham, MA
Annual Hospital - Physician Leadership                                      
 Conference MHA                               Mar 16, 2012       Waltham, MA
Annual Meeting - MHA                      June 6 - 7, 2012      Brewster, MA
SVU/SVS Annual Conference                 June 7 - 9, 2012     Baltimore, MD



About Cardiology Associates of Fairfield County (CAFC):

The mission and vision of Cardiology Associates of Fairfield County, PC (CAFC)
is to provide diagnostic testing and consultative care, in conjunction with
primary healthcare providers, to patients throughout Fairfield County,
Connecticut. It is the further mission and vision of CAFC to provide invasive
and surgical cardiovascular techniques as well as expertise in
cardiac-electrophysiology to patients. For more information, please visit the
Company's website: www.cafconline.com.


About Navix:

Since 1996, Navix has been dedicated to helping health care providers detect and
diagnose cardiovascular disease. Navix partners with hospitals and physician
practices to provide a full range of non-invasive heart & vascular diagnostic
services, including vascular ultrasound, echocardiography, nuclear medicine and
Holter monitoring. Navix's services include credentialed technologists,
advanced, clinical protocols, lab accreditation (ICAVL, ICAEL & ICANL)
consulting services, diagnostic equipment, risk-profiled stroke and vascular
screening program, as well as other marketing programs to increase the number of
patients referrals. Clinical oversight and testing interpretation services are
provided by the client physician staff. For more information, please visit the
Company's website: www.navixdiagnostix.com.


About the Medipattern Corporation:

Medipattern(R) is a pioneer in the development of imaging software solutions
that help medical practitioners to better understand lesions and critical
anatomy. Medipattern uses its Cadenza(TM) technology to process images, finding
the salient region of interest and presenting them in 2D and 3D formats that
enhance the reader's perception. For more information, please visit the
Company's website: www.medipattern.com.


Medipattern(R) is a registered mark of The Medipattern Corporation.
Visualize:Vascular(TM) is a trademark of the Medipattern Corporation.


Forward-looking statements

This document contains forward-looking statements relating to Medipattern's
performance, operations, or business environment. These statements are based on
what we believe are reasonable assumptions given currently available information
and our understanding of Medipattern's current activities. We have tried,
whenever possible, to identify these forward-looking statements using words such
as "anticipates," "believes," "estimates," "expects," "plans," "intends,"
"potential", and similar expressions. Forward-looking statements are not
guarantees of future performance and involve risks and uncertainties that are
difficult to predict or control. A number of factors could cause actual outcomes
and results to differ materially from those expressed in forward-looking
statements. These factors include but are not limited to those set forth in the
Company's corporate filings (posted at www.sedar.com). In addition, these
forward-looking statements relate to the date on which they are made. The
Company disclaims any intention or obligation to update or revise any
forward-looking statements for any reason. Readers should not rely on
forward-looking statements.

The Medipattern Corp. (TSXV:MKI)
Gráfica de Acción Histórica
De May 2024 a Jun 2024

The Medipattern Corp. (TSXV:MKI)
Gráfica de Acción Histórica
De Jun 2023 a Jun 2024